Purity
≥ 98% (HPLC)
Tesamorelin
Stabilized GHRH Analog
Tesamorelin is a stabilized GHRH analog that has been used to reduce visceral adipose tissue in HIV-associated lipodystrophy — the most clinically validated GHRH analog for fat reduction in the literature.
Studied Mechanism
Agonizes pituitary GHRH receptors to raise GH/IGF-1, with downstream effects on lipolysis and visceral-fat reduction observed in study models.
Research References
For Research Use Only — Not for Human Consumption
For laboratory research use only. Not for human consumption. Not a drug, food, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. Products are sold exclusively to qualified researchers and institutions. By purchasing, you confirm you are using these materials for lawful, in-vitro research purposes and assume all responsibility for safe handling.
Related compounds
GHRH Analog + GH Secretagogue
Growth Hormone
Ipamorelin / CJC1295
Studied Mechanism
Ipamorelin selectively agonizes the GHS-R1a receptor for pulsatile GH release; CJC-1295 acts on pituitary GHRH receptors to raise the GH/IGF-1 baseline. The combination targets complementary GH-release pathways.
GHRH (1–29) Analog
Growth Hormone
Sermorelin
Studied Mechanism
Binds pituitary GHRH receptors to stimulate endogenous growth-hormone synthesis and release in a physiologic, pulsatile manner in study models.
Key References
Mitochondrial-Derived Compound
Longevity
MOTS-C
Studied Mechanism
Studied for activating AMPK signaling and translocating to the nucleus under metabolic stress to regulate genes governing glucose handling and metabolic homeostasis in study models.
Key References